AHA provides feedback to the Food and Drug Administration on regulatory considerations for generative artificial intelligence (GenAI)-enabled medical devices.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The American Hospital Association voices support of the 340B Rebate Model Delay Act (H.R. 10770).
AHA Comments to MedPAC on MA Beneficiaries' Post-acute Care Service Utilization.
AHA comments on the bipartisan leadership in introducing the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
AHA Comments on the Department of Homeland Security’s (DHS) proposed fee for H-1B petitions.
AHA comments on the Centers for Medicare & Medicaid Services's proposed rule regarding the indirect hold harmless threshold of healthcare-related taxes.
AHA comments on the CMS physician fee schedule proposed rule for calendar year 2027.
AHA, Health organization urge congressional leaders to enact the Saving Today's Acute Care Resources (STAR) Act (H.R. 9468) without delay.
AHA comments on NAIC Health Care Affordability Issue Briefs.
AHA comments on the Center for Medicare & Medicaid Service’s calendar year 2027 HH prospective payment system (PPS) proposed rule.